$SSKN
STRATA Skin Sciences, Inc.

2021 Q4 Form 10-K Financial Statement

#000114036122010347 Filed on March 21, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 2020 Q4
Revenue $9.057M $29.98M $6.720M
YoY Change 34.78% 29.83% -24.49%
Cost Of Revenue $3.057M $10.13M $2.180M
YoY Change 40.23% 13.08% -21.3%
Gross Profit $6.000M $19.85M $4.540M
YoY Change 32.16% 40.44% -25.94%
Gross Profit Margin 66.25% 66.22% 67.56%
Selling, General & Admin $6.346M $22.82M $4.570M
YoY Change 38.86% 34.73% -23.45%
% of Gross Profit 105.77% 114.95% 100.66%
Research & Development $276.0K $1.434M $320.0K
YoY Change -13.75% 12.56% 52.38%
% of Gross Profit 4.6% 7.22% 7.05%
Depreciation & Amortization $1.047M $2.100M $800.0K
YoY Change 30.88% 5.0% -24.53%
% of Gross Profit 17.45% 10.58% 17.62%
Operating Expenses $6.622M $24.25M $4.890M
YoY Change 35.42% 33.18% -21.0%
Operating Profit -$622.0K -$4.402M -$350.0K
YoY Change 77.71% 8.0% 483.33%
Interest Expense -$206.0K $314.0K -$20.00K
YoY Change 930.0% 48.82% -75.0%
% of Operating Profit
Other Income/Expense, Net $1.730M
YoY Change -2936.07%
Pretax Income -$827.0K -$2.672M -$380.0K
YoY Change 117.63% -35.41% -30.91%
Income Tax $22.00K $34.00K $70.00K
% Of Pretax Income
Net Earnings -$849.0K -$2.706M -$440.0K
YoY Change 92.95% -38.67% -15.38%
Net Earnings / Revenue -9.37% -9.03% -6.55%
Basic Earnings Per Share
Diluted Earnings Per Share -$24.70K -$79.47K -$13.02K
COMMON SHARES
Basic Shares Outstanding 33.77M
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q4 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.59M $12.59M $10.60M
YoY Change 18.74% 18.74% 30.38%
Cash & Equivalents $12.59M $12.59M $10.60M
Short-Term Investments
Other Short-Term Assets $462.0K $462.0K $7.840M
YoY Change -94.11% -94.11% -2.12%
Inventory $3.489M $3.489M $3.444M
Prepaid Expenses
Receivables $3.433M $3.433M $2.944M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $19.97M $19.97M $24.83M
YoY Change -19.58% -19.57% 5.42%
LONG-TERM ASSETS
Property, Plant & Equipment $6.883M $7.521M $5.529M
YoY Change 24.49% 15.35% 2.98%
Goodwill $8.803M $8.803M
YoY Change 0.0% 0.0%
Intangibles $10.08M $6.345M
YoY Change 58.91% -20.24%
Long-Term Investments
YoY Change
Other Assets $216.0K $216.0K $282.0K
YoY Change -23.4% -22.86% -18.73%
Total Long-Term Assets $26.62M $26.62M $21.95M
YoY Change 21.31% 21.29% -7.74%
TOTAL ASSETS
Total Short-Term Assets $19.97M $19.97M $24.83M
Total Long-Term Assets $26.62M $26.62M $21.95M
Total Assets $46.59M $46.59M $46.78M
YoY Change -0.4% -0.4% -1.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.822M $2.822M $2.764M
YoY Change 2.1% 2.25% 47.02%
Accrued Expenses $6.377M $6.695M $4.690M
YoY Change 35.97% 32.31% -8.65%
Deferred Revenue $3.285M $2.262M
YoY Change 45.23% -20.13%
Short-Term Debt $0.00 $0.00 $7.280M
YoY Change -100.0% -100.0% 0.0%
Long-Term Debt Due $0.00 $0.00 $1.478M
YoY Change -100.0% -100.0%
Total Short-Term Liabilities $12.80M $12.80M $18.84M
YoY Change -32.04% -32.05% 8.05%
LONG-TERM LIABILITIES
Long-Term Debt $7.319M $7.319M $1.050M
YoY Change 597.05% 597.05%
Other Long-Term Liabilities $792.0K $792.0K $34.00K
YoY Change 2229.41% 7.03% -80.9%
Total Long-Term Liabilities $7.319M $8.111M $1.084M
YoY Change 575.18% 353.13% 508.99%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.80M $12.80M $18.84M
Total Long-Term Liabilities $7.319M $8.111M $1.084M
Total Liabilities $21.18M $21.18M $20.89M
YoY Change 1.4% 1.38% 11.75%
SHAREHOLDERS EQUITY
Retained Earnings -$221.7M -$219.0M
YoY Change 1.24% 2.06%
Common Stock $34.00K $34.00K
YoY Change 0.0% 3.03%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $25.41M $25.41M $25.89M
YoY Change
Total Liabilities & Shareholders Equity $46.59M $46.59M $46.78M
YoY Change -0.4% -0.4% -1.19%

Cashflow Statement

Concept 2021 Q4 2021 2020 Q4
OPERATING ACTIVITIES
Net Income -$849.0K -$2.706M -$440.0K
YoY Change 92.95% -38.67% -15.38%
Depreciation, Depletion And Amortization $1.047M $2.100M $800.0K
YoY Change 30.88% 5.0% -24.53%
Cash From Operating Activities $669.0K $1.508M $350.0K
YoY Change 91.14% -28.05% -68.47%
INVESTING ACTIVITIES
Capital Expenditures -$1.130M $3.653M -$710.0K
YoY Change 59.15% 69.2% -49.65%
Acquisitions $3.473M
YoY Change
Other Investing Activities $0.00 -$3.473M
YoY Change
Cash From Investing Activities -$1.130M -$7.126M -$710.0K
YoY Change 59.15% 230.06% -49.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $500.0K
YoY Change
Cash From Financing Activities 0.000 92.00K 20.00K
YoY Change -100.0% -96.39% -106.67%
NET CHANGE
Cash From Operating Activities 669.0K 1.508M 350.0K
Cash From Investing Activities -1.130M -7.126M -710.0K
Cash From Financing Activities 0.000 92.00K 20.00K
Net Change In Cash -461.0K -5.526M -340.0K
YoY Change 35.59% -322.55% -43.33%
FREE CASH FLOW
Cash From Operating Activities $669.0K $1.508M $350.0K
Capital Expenditures -$1.130M $3.653M -$710.0K
Free Cash Flow $1.799M -$2.145M $1.060M
YoY Change 69.72% 3304.76% -57.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001051514
CY2021 dei Auditor Firm
AuditorFirmId
688
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
0-11635
CY2021 dei Entity Registrant Name
EntityRegistrantName
STRATA SKIN SCIENCES, INC.
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-3986004
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
5 Walnut Grove Drive
CY2021 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 140
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Horsham
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19044
CY2021 dei City Area Code
CityAreaCode
215
CY2021 dei Local Phone Number
LocalPhoneNumber
619-3200
CY2021 dei Security12b Title
Security12bTitle
Common Stock, $0.001 Par Value
CY2021 dei Trading Symbol
TradingSymbol
SSKN
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
true
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
25923351
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
34723046
CY2021 dei Auditor Name
AuditorName
Marcum LLP
CY2021 dei Auditor Location
AuditorLocation
Philadelphia, Pennsylvania
CY2021Q4 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
0
CY2020Q4 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
7275000
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1478000
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021 us-gaap Operating Expenses
OperatingExpenses
24252000
CY2020 us-gaap Operating Expenses
OperatingExpenses
18210000
CY2020 sskn Conversion Of Convertible Preferred Stock Amount
ConversionOfConvertiblePreferredStockAmount
0
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0
CY2021 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
585000
CY2021 sskn Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-369000
CY2020 sskn Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-312000
CY2021 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
3473000
CY2020 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3653000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2159000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
18000
CY2021 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-style: normal; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">Reclassifications</div> <div style="font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;"> <br/> </div> <div style="display:none;"><br/></div> <div style="font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; text-align: left;">Certain reclassifications from the prior year presentation have been made to conform to the current year presentation.</div>
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12586000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10604000
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
0
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
7508000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12586000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18112000
CY2021 us-gaap Number Of Reporting Units
NumberOfReportingUnits
2
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2020Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
113000
CY2019Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
232000
CY2021 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
71000
CY2020 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
67000
CY2021 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
105000
CY2020 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
186000
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
79000
CY2020Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
113000
CY2021Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
59000
CY2020Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
87000
CY2021Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
20000
CY2020Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
26000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29977000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23090000
CY2019 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
200000
CY2021Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
26000
CY2020Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
115000
CY2021Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
12000
CY2020Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
108000
CY2020Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2021Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2021Q4 sskn Contract With Customer Liability Current Advance Consideration
ContractWithCustomerLiabilityCurrentAdvanceConsideration
12000
CY2020Q4 sskn Contract With Customer Liability Current Advance Consideration
ContractWithCustomerLiabilityCurrentAdvanceConsideration
108000
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
14000
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
7000
CY2020 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
100000
CY2021 us-gaap Advertising Expense
AdvertisingExpense
1600000
CY2020 us-gaap Advertising Expense
AdvertisingExpense
700000
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4402779
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5312700
CY2021Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
3201000
CY2020Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
2949000
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
288000
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
495000
CY2021Q4 us-gaap Inventory Net
InventoryNet
3489000
CY2020Q4 us-gaap Inventory Net
InventoryNet
3444000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
11331000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
10083000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
16100000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9755000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
26654000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
23374000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19771000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
17845000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6883000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5529000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2100000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2000000.0
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
89000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
710000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
21414000
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
400000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
400000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
500000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
400000
CY2020 sskn Operating Lease Incremental Borrowing Rate Percent
OperatingLeaseIncrementalBorrowingRatePercent
0.0976
CY2021 sskn Operating Lease Incremental Borrowing Rate Percent
OperatingLeaseIncrementalBorrowingRatePercent
0.0976
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y3M18D
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y1M6D
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
371000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
242000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
186000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
799000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6345000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1600000
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1600000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1853000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1853000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1853000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1148000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
443000
CY2021Q4 us-gaap Goodwill
Goodwill
8803000
CY2020Q4 us-gaap Goodwill
Goodwill
8803000
CY2021Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
59000
CY2020Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
87000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2052000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
891000
CY2021Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
3697000
CY2020Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
3105000
CY2021Q4 sskn Accrued Professional Fees Other Accrued Liabilities
AccruedProfessionalFeesOtherAccruedLiabilities
569000
CY2020Q4 sskn Accrued Professional Fees Other Accrued Liabilities
AccruedProfessionalFeesOtherAccruedLiabilities
607000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6377000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4690000
CY2021 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
300000
CY2020 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
200000
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
1000000
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
4000000
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
3000000
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
8000000
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
329076
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
15000
CY2021 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
234558
CY2020 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
71683
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
1600000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
1600000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
200000
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y11M15D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.9003
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.9400
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0108
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0053
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P0Y6M
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
22000
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
21000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
22000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
21000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
23000
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
129000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-11000
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
125000
CY2021 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
12000
CY2020 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
254000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
275000
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
46596000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
45819000
CY2020Q4 sskn Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
272000
CY2021Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
667000
CY2020Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
0
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
48457000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29977000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
48308000
CY2021Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
950000
CY2020Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
815000
CY2021Q4 sskn Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
177000
CY2021Q4 sskn Deferred Tax Assets Intangible Assets
DeferredTaxAssetsIntangibleAssets
1039000
CY2020Q4 sskn Deferred Tax Assets Intangible Assets
DeferredTaxAssetsIntangibleAssets
1450000
CY2021Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
26000
CY2020Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
51000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
1230000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
896000
CY2021Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
441000
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
178000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
458000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
808000
CY2021Q4 sskn Deferred Tax Liabilities Right Of Use Asset
DeferredTaxLiabilitiesRightOfUseAsset
159000
CY2020Q4 sskn Deferred Tax Liabilities Right Of Use Asset
DeferredTaxLiabilitiesRightOfUseAsset
249000
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
266000
CY2020Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
254000
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
100000
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1200000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.0033
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0659
CY2021 sskn Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
0.0890
CY2020 sskn Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.0275
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.2527
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0258
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.0557
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.2890
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0127
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0664
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23090000
CY2020 us-gaap Cost Of Revenue
CostOfRevenue
8956000
CY2020 us-gaap Gross Profit
GrossProfit
14134000
CY2020 sskn Percentage Of Gross Profit
PercentageOfGrossProfit
0.612
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1274000
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
10127000
CY2021 us-gaap Gross Profit
GrossProfit
19850000
CY2021 sskn Percentage Of Gross Profit
PercentageOfGrossProfit
0.662
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1434000
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
13106000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9712000
CY2021 us-gaap Operating Expenses
OperatingExpenses
24252000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-4402000
CY2021 us-gaap Interest Expense
InterestExpense
314000
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
15000
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
2029000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2672000
CY2020 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9038000
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7898000
CY2020 us-gaap Operating Expenses
OperatingExpenses
18210000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-4076000
CY2020 us-gaap Interest Expense
InterestExpense
211000
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
150000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4137000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29977000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23090000
CY2021Q4 us-gaap Assets
Assets
46593000
CY2020Q4 us-gaap Assets
Assets
46778000

Files In Submission

Name View Source Status
0001140361-22-010347-index-headers.html Edgar Link pending
0001140361-22-010347-index.html Edgar Link pending
0001140361-22-010347.txt Edgar Link pending
0001140361-22-010347-xbrl.zip Edgar Link pending
brhc10035383_10k.htm Edgar Link pending
brhc10035383_10k_htm.xml Edgar Link completed
brhc10035383_ex10-79.htm Edgar Link pending
brhc10035383_ex10-84.htm Edgar Link pending
brhc10035383_ex23-1.htm Edgar Link pending
brhc10035383_ex31-1.htm Edgar Link pending
brhc10035383_ex31-2.htm Edgar Link pending
brhc10035383_ex32-1.htm Edgar Link pending
brhc10035383_ex4-16.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
sskn-20211231.xsd Edgar Link pending
sskn-20211231_cal.xml Edgar Link unprocessable
sskn-20211231_def.xml Edgar Link unprocessable
sskn-20211231_lab.xml Edgar Link unprocessable
sskn-20211231_pre.xml Edgar Link unprocessable